These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 13536201)

  • 1. The influence of certain ganglionic blocking agents on neuromuscular transmission.
    DEACOCK AR; DAVIES TD
    Br J Anaesth; 1958 May; 30(5):217-25. PubMed ID: 13536201
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of certain ganglionic blocking agents on neuromuscular transmission.
    DEACOCK AR; HARGROVE RL
    Br J Anaesth; 1962 Jun; 34():357-62. PubMed ID: 13884604
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of mecamylamine on the action of certain other ganglionic blocking agents.
    PAYNE JP
    Br J Anaesth; 1957 Aug; 29(8):358-62. PubMed ID: 13460132
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of ganglionic blocking agents on the neuromuscular junction.
    Chiou CY
    Eur J Pharmacol; 1970; 12(3):342-7. PubMed ID: 4395556
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on cholinergic-blocking substances. VI. The pharmacology of hexamethonium- and pendiomid type ganglionic-blocking compounds.
    GYERMEK L
    Acta Physiol Acad Sci Hung; 1954; 5(1-2):163-79. PubMed ID: 13147923
    [No Abstract]   [Full Text] [Related]  

  • 6. Channel-blocking mechanism ensures specific blockade of synaptic transmission.
    Skok VI
    Neuroscience; 1986; 17(1):1-9. PubMed ID: 2421197
    [No Abstract]   [Full Text] [Related]  

  • 7. The physiological action of neuromuscular and ganglionic blocking agents.
    BURN JH
    Br J Anaesth; 1957 Jun; 29(6):242-8. PubMed ID: 13436684
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuromuscular and ganglionic blocking action of thiamine and its derivatives.
    DI PALMA JR; HITCHCOCK P
    Anesthesiology; 1958; 19(6):762-9. PubMed ID: 13595256
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological properties of some analogues of 2-imino-4-ethyloxycarbonyl-1,3-diazacycloheptane hydrochloride (OG 30), a ganglionic stimulant.
    Saxena PR; van Riezen H; Panneman HJ
    Arch Int Pharmacodyn Ther; 1970 May; 185(1):159-73. PubMed ID: 5470016
    [No Abstract]   [Full Text] [Related]  

  • 10. Ganglion-blocking activity of bisquaternary ammonium salts derived from 3 ,12 -diamino-5 -cholane and 3 ,12 -diamino-24-nor-5 -cholane.
    Marshall IG; Martin-Smith M
    Eur J Pharmacol; 1972 Jan; 17(1):39-43. PubMed ID: 4401433
    [No Abstract]   [Full Text] [Related]  

  • 11. Supersensitivity due to prolonged administration of ganglion-blocking compounds.
    EMMELIN N
    Br J Pharmacol Chemother; 1959 Jun; 14(2):229-33. PubMed ID: 13662579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of dihydrochandonium and other chandonium analogues on neuromuscular and autonomic transmission.
    Teerapong P; Marshall IG; Harvey AL; Singh H; Paul D; Bhardwaj TR; Ahuja NK
    J Pharm Pharmacol; 1979 Aug; 31(8):521-8. PubMed ID: 39992
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neuromuscular block].
    DALLEMAGNE MJ; PHILIPPOT E
    Acta Anaesthesiol; 1952 Nov; 3(2-3):125-39. PubMed ID: 13030108
    [No Abstract]   [Full Text] [Related]  

  • 14. [A modification of the isolated hypogastric nerve-vas deferens preparation from the guinea pig for assay of ganglionic actions].
    Watanabe M
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(2):221-7. PubMed ID: 4389237
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of ganglionic blocking agents.
    MAINLAND JF; SHAW FH
    Nature; 1952 Sep; 170(4323):418-9. PubMed ID: 12993186
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of ganglion blocking agents on metabolic variations].
    GUGLIELMI F; BELSASSO E
    G Ital Anestesiol; 1952; 18(5):530-4. PubMed ID: 13021502
    [No Abstract]   [Full Text] [Related]  

  • 17. The comparative effects of four ganglionic blocking agents on the cardiovascular system of man.
    WINSOR T
    Am J Med Sci; 1955 Aug; 230(2):133-42. PubMed ID: 14398691
    [No Abstract]   [Full Text] [Related]  

  • 18. [Development of inflammatory processes in animals subjected to autonomic block with ganglion-blocking agents].
    MIGNANI E; GRAEV M
    Arch De Vecchi Anat Patol; 1955 Apr; 23(1):115-48. PubMed ID: 13259824
    [No Abstract]   [Full Text] [Related]  

  • 19. The ganglionic blocking activity of a series of 4-aminoethylpiperidine derivatives.
    COLVILLE KI; FANELLI RV
    J Am Pharm Assoc Am Pharm Assoc; 1956 Nov; 45(11):727-9. PubMed ID: 13376360
    [No Abstract]   [Full Text] [Related]  

  • 20. [ON THE NATURE OF THE NEUROMUSCULAR BLOCK CAUSED BY D-TUBOCURARINE, HEXAMETHONIUM, PEMPIDINE, NICOTINE AND DIMETHYLPHENYLPIPERAZINIUM].
    BEANI L; BIANCHI C
    Arch Sci Biol (Bologna); 1964; 48():50-62. PubMed ID: 14217694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.